D. N. Carney
- Oncology top 10%
- Molecular Biology
- Epidemiology
- Cell Biology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Adi F. GazdarJohn D. MinnaG. Peter VooijsPaul J. MarangosM H ZweigStephen B. BaylinJos L. V. BroersGert Schaart
- Topics
- Lung Cancer Research Studies (14 papers)Neuroendocrine Tumor Research Advances (8 papers)Peptidase Inhibition and Analysis (5 papers)
- Cited by
- OncologyCell BiologyCancer Research
- Partner nations
- United StatesIrelandNetherlands
In The Last Decade
D. N. Carney
25 papers receiving 653 citations
Peers
Comparison fields: 5 of 67
- Oncology 375
- Molecular Biology 339
- Epidemiology 184
- Cell Biology 125
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by D. N. Carney
This map shows the geographic impact of D. N. Carney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. N. Carney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. N. Carney more than expected).
Fields of papers citing papers by D. N. Carney
This network shows the impact of papers produced by D. N. Carney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. N. Carney. The network helps show where D. N. Carney may publish in the future.
Co-authorship network of co-authors of D. N. Carney
This figure shows the co-authorship network connecting the top 25 collaborators of D. N. Carney. A scholar is included among the top collaborators of D. N. Carney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. N. Carney. D. N. Carney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 104 | |
| 3 | 15 | |
| 4 | The biology of lung cancer. | 6 |
| 5 | 15 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 33 | |
| 10 | In vitro chemosensitivity of human lung cancer cell lines. | 12 |
| 11 | 2 | |
| 12 | 13 | |
| 13 | The use of human lung cancer cell lines for in vitro chemosensitivity testing | 3 |
| 14 | 38 | |
| 15 | Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. | 4 |
| 16 | Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. | 16 |
| 17 | Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. | 7 |
| 18 | Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. | 114 |
| 19 | Small cell carcinoma of the lung: altered morphological, bio- logical and biochemical characteristics in long term cultures and heterotransplanted tumors. Abstr. | 8 |
| 20 | 0 |
About D. N. Carney
D. N. Carney is a scholar working on Oncology, Epidemiology and Physiology, having authored 26 papers that have together received 709 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (8 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Oncology (375 citations), Cell Biology (125 citations) and Cancer Research (86 citations). D. N. Carney has collaborated with scholars based in United States, Ireland and Netherlands. Frequent co-authors include Adi F. Gazdar, John D. Minna, G. Peter Vooijs, Paul J. Marangos, M H Zweig, Stephen B. Baylin, Jos L. V. Broers, Gert Schaart, Frans C. S. Ramaekers and E. Birgitte Lane. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.